Pages
- About Us
- Annual Reports
- Bora Prescription Drugs
- Business
- Careers
- Contact Us
- Corporate Emergency Response Measures
- EHS Management Measures
- Home
- Information Security
- Investors
- Audit Committee
- Audit Committee Implementation
- Audit Committee Operating Conditions
- Auditor’s Independence
- Board Diversity and Succession Plan
- Board of Director Performance Evaluation
- Board of Directors
- Board of Directors Implementation
- Compensation Committee
- Compensation Committee Implementation
- Corporate Governance Officer
- Download Report
- Ethical Management and Prevention of Insider Trading
- Financial Statements
- Intellectual Property Management Plan
- List of Main Shareholders
- Major Internal Policies
- Quarterly Results
- Shareholder Services
- Vision for Sustainability and Development Strategies
- Legal Compliance
- Monthly Results
- News & Events
- R&D
- Risk Management
- Sitemap
- Sustainable Development
Posts by category
- Category: Awards
- Bora Recognized with Dual Accolades at Asia Best Companies to Work for Awards 2024
- Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake
- Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen
- Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023
- CEO Bobby Sheng wins CEO of the Year at CPhI Awards 2020
- Best Companies to Work for in Taiwan 2019 Awards
- 2018 Taiwan MAPECT Taiwan M&A Awards
- 12th Annual Top 10 Potential Business Gold Torch Award
- Category: Events
- Category: News
- Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
- Bora Appoints J.D. Mowery As First Division President Of Its CDMO Business
- Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
- Bora Pharmaceuticals Makes a Strategic Investment into Tanvex to Provide Global BioManufacturing Services.
- Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent
- Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility
- Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
- SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient
- Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
- Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey
- Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing
- Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
- Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
- Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market
- Bora Pharmaceuticals to expand operations with $10m investment
- Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
- KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan